Skip to content Menu
Science Chronicle

Science Chronicle

A Science and Technology Blog

Sidebar
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad

Category: Pharmaceutical companies

Posted on January 15, 2021January 15, 2021

Indian scientists divided over restricted use approval for Covaxin

In a tweet on January 14, the Health Ministry said both Covishield and Covaxin approved for restricted use by the Indian regulator are safe. The Health Ministry released a statement…

Continue Reading
Posted on January 15, 2021January 15, 2021

Vaccine dilemma: To take or not to take Covaxin

True, in the U.S., vaccines from both Pfizer and Moderna are available and recipients, who are health-care workers and nursing home residents, have no option to choose the vaccine. In…

Continue Reading
Posted on January 13, 2021

Serious violations in Covaxin trial in Bhopal show nothing has changed since the egregious HPV vaccine trial

The phase-3 clinical trial of Bharat Biotech’s COVID-19 vaccine, Covaxin, by a private hospital in the Bhopal-based Peoples College of Medical Sciences & Research Centre appears to suffer from serious…

Continue Reading
Posted on January 8, 2021

I would not take Covaxin without efficacy data: Gagandeep Kang

Scientists, manufacturers and drug regulators have been speeding up the timelines to develop, test and approve vaccines for emergency use. Three safe and efficacious vaccines from Pfizer, Moderna and AstraZeneca…

Continue Reading
Posted on January 5, 2021January 5, 2021

With hasty approval, India squanders an opportunity to build trust in COVID-19 vaccine

Transparency in the approval process is vital for gaining the trust of people so that they don’t hesitate to take the vaccine. If there is already some degree of anxiety…

Continue Reading
Posted on January 3, 2021

Why people with prior SARS-CoV-2 infection still need to be vaccinated

Since vaccine shortage is expected to last at least for a few months, it may seem appealing to delay or avoid vaccinating those who have been naturally infected. But does…

Continue Reading
Posted on January 2, 2021

UK uses an untested strategy to rapidly but partially protect people at risk

With the virus running amok in the country and vaccines in short-supply, the U.K. is attempting an untested strategy of delaying the second dose of both AstraZeneca and Pfizer vaccine even in the absence of data from large trials. The intent is to rapidly but partially protect more individuals who are at risk.

Continue Reading
Posted on December 28, 2020

Why a dry run for COVID vaccination is needed

This is the first time a vaccine to be administered outside the universal immunisation programme and specifically for adults is to be rolled out. Since several aspects of the COVID vaccination programme are new, the government has rightly decided to undertake a dry-run for vaccine administration.

Continue Reading

Posts navigation

Page 1 Page 2 … Page 12 Next Page
Follow Science Chronicle on WordPress.com

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 10,593 other followers

Archives

Social

  • View Prasad.Ravindranath’s profile on Facebook
  • View @RPrasad12’s profile on Twitter
  • View Prasad.Ravindranath@gmail.com’s profile on Google+

Recent Posts

  • Glitches in CoWIN also responsible for low COVID-19 vaccine uptake January 23, 2021
  • Indian scientists divided over restricted use approval for Covaxin January 15, 2021
  • Vaccine dilemma: To take or not to take Covaxin January 15, 2021
  • Serious violations in Covaxin trial in Bhopal show nothing has changed since the egregious HPV vaccine trial January 13, 2021
  • New challenges in conducting COVID-19 vaccine trials in India January 9, 2021

Most Read Posts

  • Manipulation within a photo should always result in a retraction: Elisabeth Bik
  • I would not take Covaxin without efficacy data: Gagandeep Kang
  • Two-layered polypropylene mask doubly better than a single-layered cotton mask, study finds
  • Vaccine dilemma: To take or not to take Covaxin
  • 'Serum’s pneumococcal vaccine will be available by June 2020'
  • Easy way to tell if the foil used in Thanjavur painting is gold or fake
  • UGC’s revised white list has 71 active predatory journals
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
Create a website or blog at WordPress.com
Top
Follow Science Chronicle on WordPress.com

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 10,593 other followers

Archives

Cancel